Gabapentin adjunctive therapy in neuropathic pain states

Clinical Journal of Pain

Volumn 12, Issue 1, 1996, Pages 56-58

  Rosner, Howard ^a   Rubin, Lori ^a   Kestenbaum, Alan ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Antiepileptic drugs; Gabapentin; Neuropathic pain

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN;

ADULT; AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; MALE; NEUROPATHY; OUTPATIENT; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; SELF REPORT;

ACETIC ACIDS; ADULT; AGED; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; FACIAL PAIN; FEMALE; GAMMA-AMINOBUTYRIC ACID; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; INTERVERTEBRAL DISK DISPLACEMENT; MALE; MIDDLE AGED; NEURALGIA; PAIN, INTRACTABLE; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0029993650     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-199603000-00010     Document Type: Article

References (7)

1. Loeser JD. Peripheral nerve disorders (peripheral neuropathies). In: Bonica JJ, Loeser JD, Chapman CR, Fordyce WE, eds. The management of pain. 2nd ed. Philadelphia: Lea & Febiger, 1990:211-8.
2. U.S. Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993;43: 2292-8.
3. Mellick LB, Mellick GA. Successful treatment of reflex sympathetic dystrophy with gabapentin [Letter]. Am J Emerg Med 1995;13:96.
4. MacDonald RL, Kelly KM. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 1994;35(suppl 4):S41-50.
5. Hill DR, Suman-Chauhan N, Woodruff GN. Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol 1993;244:303-9.
6. Rall TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The pharmacologic basis of therapeutics. 8th ed. New York: McGraw-Hill, 1993:436-62.
7. Andrews CO, Fischer JH. Gabapentin: a new agent for the management of epilepsy. Ann Pharmacother 1994;28:1188-96.